Showing results (11-20 of 50) with videos related to
Sort By:
Pageof 5
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 27, 2019
Determination of 6-thioguanine and 6-methylmercaptopurine in dried blood spots using liquid chromatography-tandem mass spectrometry: Method development, validation and clinical applicationKristina Lampič, Jurij Trontelj, Helena Prosen, et al.Frontiers in Medicine|May 21, 2020
Pathology of Fibrosis in Crohn's Disease-Contribution to Understanding Its PathogenesisNina Zidar, Cord Langner, Miha Jerala, et al.European Journal of Gastroenterology & Hepatology|February 19, 2025
First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitisEva Supovec, Jurij Hanžel, Gregor Novak, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 22, 2023
Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel DiseaseTomislav Jukic, David Drobne, Sasa Pusavec, et al.Biochemia Medica|April 30, 2021
The comparison of the three assays for determination of fecal calprotectin in inflammatory bowel diseaseJoško Osredkar, Tina Kurent, Teja Fabjan, et al.Journal of Cellular and Molecular Medicine|April 27, 2016
Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transitionNina Zidar, Emanuela Boštjančič, Miha Jerala, et al.Medicina (Kaunas, Lithuania)|February 24, 2024
Remission Is Maintained after Switch from Dose-Optimised Intravenous Treatment to Subcutaneous Treatment with Vedolizumab in Inflammatory Bowel DiseaseŠpela Pintar, Jurij Hanžel, David Drobne, et al.Immunologic Research|December 21, 2018
Routinely utilized in-house assays for infliximab, adalimumab and their anti-drug antibody levelsManca Ogrič, Polona Žigon, David Drobne, et al.Radiology and Oncology|December 5, 2018
Dendritic cell profiles in the inflamed colonic mucosa predict the responses to tumor necrosis factor alpha inhibitors in inflammatory bowel diseaseNatasa Smrekar, David Drobne, Lojze M Smid, et al.European Journal of Gastroenterology & Hepatology|March 26, 2023
Biopsies from ulcer edge yield higher histological activity scores than biopsies from non-ulcerated mucosa in active ulcerative colitisGregor Novak, Nejc Sever, Jurij Hanžel, et al.Pageof 5